SignaCor Therapeutics

ST
SI

SignaCor Therapeutics

Clinical-stage drug development company advancing treatments for hypertrophic cardiomyopathy and cardiovascular health.

2024ActiveBelfast, United Kingdom
Rate

About

SignaCor Therapeutics is a clinical-stage drug development company spun out from Queen's University Belfast. They are developing first-in-class therapies for symptomatic hypertrophic cardiomyopathy (HCM) that target underlying disease pathology to reverse heart damage and improve patient outcomes.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to SignaCor Therapeutics?

People comparing tools land here. Get listed beside these.

All funding rounds

Key facts

Headquarters
Belfast, United Kingdom
Founded
2024
Total funding
$315K (Seed)
Founders
Dr. Chris Watson, Darach Neeson
Business model
B2B

Funding rounds

Funding rounds raised by SignaCor Therapeutics
DateRoundAmountLead investors
9 Mar 2026Seed$315KZINC

Get notified when SignaCor Therapeutics changes

Used SignaCor Therapeutics? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Is SignaCor Therapeutics growing?

Yes, fast. Our data shows it raised $315K in a Seed in March 2026.

Who owns SignaCor Therapeutics?

SignaCor Therapeutics is privately held, owned by its founders and investors. Investors on record include ZINC. Exact stakes are not public.

Are there companies like SignaCor Therapeutics?

Yes. We list 6 companies like SignaCor Therapeutics, including Grundium, Verily and Epitel, Inc..

How much funding has SignaCor Therapeutics raised?

SignaCor Therapeutics has raised a total of $315K in funding. The most recent round on record is Seed.

SEC filings, insider activity, nonprofit links and pay benchmarks for SignaCor Therapeutics:

Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch SignaCor Therapeutics and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini